financingNovadip Biosciences SA raises €40mLatest NewsWth a Series B €40m financing, Novadip Biosciences SA has raised investements to a total of €88m. It will use the proceeds to push two single-use cell therapies designed to accelerate healing. Read more 7 November 2022 https://european-biotechnology.com/wp-content/uploads/2024/04/_c__ccfb_pixabay.com.jpg 633 960 Margarita Milidakis /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Margarita Milidakis2022-11-07 10:44:272024-07-16 12:26:45Novadip Biosciences SA raises €40m